Cargando…

Blood transfusion requirements and filter longevity with regional citrate anticoagulation compared with heparin

Detalles Bibliográficos
Autores principales:	Burford, E, Walter, E, Beverly, A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2015
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4796764/ http://dx.doi.org/10.1186/2197-425X-3-S1-A462

Ejemplares similares

Blood epuration of middle molecules in continuous venovenous hemodiafiltration with regional citrate anticoagulation versus systemic heparinization
por: Nogier, MB, et al.
Publicado: (2009)

Recurrent early filter clotting in regional citrate anticoagulated continuous venovenous hemodialysis due to undetected antibodies to heparin-platelet factor 4 complexes
por: Slowinski, T, et al.
Publicado: (2010)

Heparin-free regional anticoagulation of haemodialysis filters with calcium-free dialysate: is citrate mandatory?
por: Medrano, Chloé, et al.
Publicado: (2021)

Regional citrate anticoagulation in CVVH: a new protocol combining citrate solution with a phosphate-containing replacement fluid
por: Morabito, S, et al.
Publicado: (2012)

Regional citrate anticoagulation in high-volume continuous venovenous hemodialysis
por: Kalb, R, et al.
Publicado: (2011)

Multicenter prospective observational study on safety and efficacy of regional citrate anticoagulation in CVVHD in the presence of liver failure: the Liver Citrate Anticoagulation Threshold Study (L-CAT)
por: Slowinski, T, et al.
Publicado: (2011)

Regional citrate anticoagulation with a low-concentration solution in predilution-postdilution CVVH
por: Pistolesi, V, et al.
Publicado: (2012)

Association between type of anticoagulation and blood transfusion requirements during renal replacement therapy in the ICU
por: Iyer, A, et al.
Publicado: (2011)

Effects of two different regional citrate anticoagulation CVVH protocols on acid-base status and phosphate supplementation
por: Morabito, S, et al.
Publicado: (2013)

Pilot study on a regional citrate anticoagulated continuous venovenous hemodiafiltration protocol with variable treatment dose
por: Slowinski, T, et al.
Publicado: (2010)

Stability of citrate and calcium dosing in citrate renal replacement therapy
por: Sadaat, F, et al.
Publicado: (2015)

Citrate Anticoagulation for CRRT in Children: Comparison with Heparin
por: Fernández, Sara Nicole, et al.
Publicado: (2014)

Clinical Trial Comparing the Efficacy and Safety of Regional Citrate Anticoagulation Versus Heparin in CRRT
por: Senthilkumar, S, et al.
Publicado: (2023)

Impact of continuous veno-venous hemodiafiltration with regional citrate anticoagulation on the acid-base balance of critically ill patients
por: Passos, RH, et al.
Publicado: (2006)

Super high-flux CVVHD using regional citrate anticoagulation: long-term stability of middle molecule clearance
por: Siebeck, M, et al.
Publicado: (2015)

Dynamics of the dosage of citrate-calciuminfusion regimens as anticoagulation in continuous venovenous hemodiafiltration
por: Marin Mateos, H, et al.
Publicado: (2015)

The implementation of a blood conservation strategy in critical care on transfusion requirements
por: Tridente, A, et al.
Publicado: (2015)

Citrate anticoagulation for continuous venovenous haemodiafiltration: the impact of a novel protocol on patients receiving therapy in one regional hospital
por: Highgate, J, et al.
Publicado: (2015)

Preventing continuous renal replacement therapies (CRRT)-induced hypophosphatemia using a phosphate-containing CRRT solution in the setting of regional citrate anticoagulation
por: Pistolesi, V, et al.
Publicado: (2014)

Citrate anticoagulation realized as CVVHD using a newly designed dialysate solution
por: Morgera, S, et al.
Publicado: (2006)

Comparison of the efficacy and safety of two regional citrate anticoagulation protocols using acid citrate dextrose A or Prismocitrate 10/2, in patients with acute renal failure undergoing continuous venovenous haemodiafiltration
por: Ooi, EL, et al.
Publicado: (2010)

Regional citrate anticoagulation versus systemic heparin anticoagulation for continuous kidney replacement therapy in intensive care
por: Doidge, James C., et al.
Publicado: (2023)

Regional Anticoagulation with Citrate is Superior to Systemic Anticoagulation with Heparin in Critically Ill Patients Undergoing Continuous Venovenous Hemodiafiltration
por: Park, Joon-Sung, et al.
Publicado: (2011)

Heparin anticoagulation versus regional citrate anticoagulation for membrane therapeutic plasma exchange in patients with increased bleeding risk
por: Jiao, Jing, et al.
Publicado: (2023)

Impact of critical illness severity on transfusion requirements
por: Evagelopoulou, P, et al.
Publicado: (2006)

Citrate anticoagulation protocol to treat septic shock patients with liver dysfunction in CPFA extracorporeal therapy
por: Ferrari, F, et al.
Publicado: (2012)

Bivalirudin or heparin: which anticoagulation strategy for critically ill cardiac surgery patients?
por: Pappalardo, F, et al.
Publicado: (2014)

Novel blood product transfusion regimen to prevent clotting and citrate accumulation during continuous renal replacement therapy with regional citrate anticoagulation in children
por: Sun, Yuelin, et al.
Publicado: (2023)

Anticoagulation during continuous renal replacement therapy with lepirudin in patients with heparin-induced thrombocytopenia
por: Schroeder, T, et al.
Publicado: (2005)

Clinical review: Anticoagulation for continuous renal replacement therapy - heparin or citrate?
por: Oudemans-van Straaten, Heleen M, et al.
Publicado: (2011)

Comparison between nafamostat mesilate and unfractionated heparin as anticoagulant during continuous renal replacement therapy
por: Makino, S, et al.
Publicado: (2015)

Blood transfusion during cardiac surgery: massive transfusion coagulopathy
por: Trlaja, A, et al.
Publicado: (2013)

Regional Citrate Anticoagulation or Heparin Anticoagulation for Renal Replacement Therapy in Patients With Liver Failure: A Systematic Review and Meta-Analysis
por: Qi, Wenqian, et al.
Publicado: (2023)

Combined use of pumpless extracorporeal lung assist system and continuous renal replacement therapy with citrate anticoagulation in polytrauma patients
por: Atalan, HK, et al.
Publicado: (2013)

Analysis of Leukocyte Recruitment in Continuous Veno-Venous Hemofiltration with Regional Citrate vs. Systemic Heparin Anticoagulation
por: Margraf, Andreas, et al.
Publicado: (2022)

Use of activated clotting time to monitor anticoagulation in patients receiving unfractionated heparin on renal replacement therapy
por: Bidwai, A, et al.
Publicado: (2011)

Discrepant post filter ionized calcium concentrations by common blood gas analyzers in CRRT using regional citrate anticoagulation
por: Schwarzer, Patrik, et al.
Publicado: (2015)

Citrate versus heparin anticoagulation in continuous renal replacement therapy in small children
por: Raymakers-Janssen, Paulien A. M. A., et al.
Publicado: (2017)

Transfusion requirements in septic shock patients: a randomized controlled trial
por: Bergamin, F, et al.
Publicado: (2014)

Massive blood transfusion for obstetric haemorrhage
por: Simmons, S, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_1v78oqm2hvka190o4ee55de1jv